Equitable Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Equitable Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.67B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $12.43B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $10.46B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $12.64B | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $7.61B | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $12.42B | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | $1.69B | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $3.03B | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $3.16B | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $1.71B | Feb 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.38B) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.28B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.28B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $2.15B | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $1.76B | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | ($648.00M) | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | ($937.00M) | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | ($384.00M) | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $363.00M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | ($775.00M) | Feb 27, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $714.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.01B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | ($208.00M) | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | ($250.00M) | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | ($193.00M) | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | ($61.00M) | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | ($216.00M) | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $61.00M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | ($243.00M) | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | ($236.00M) | Mar 8, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $317.99B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $295.73B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $276.70B | Feb 25, 2026 |
| FY2023 | Dec 31, 2022 | $252.70B | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $292.26B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $275.40B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $249.82B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $220.80B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $235.62B | Mar 8, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $316.20B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $292.18B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $271.55B | Feb 25, 2026 |
| FY2023 | Dec 31, 2022 | $249.11B | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $278.70B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $258.08B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $234.41B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $205.18B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $218.47B | Mar 8, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($74.00M) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.57B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $2.64B | Feb 25, 2026 |
| FY2023 | Dec 31, 2022 | $1.40B | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $11.52B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $15.58B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $13.46B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $13.87B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $13.42B | Mar 8, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $4.57B | Mar 8, 2019 |
| FY2018 | Dec 31, 2017 | $4.57B | Mar 8, 2019 |
| FY2018 | Dec 31, 2016 | $4.94B | Mar 8, 2019 |
| FY2018 | Dec 31, 2015 | $4.92B | Mar 8, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.37B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $10.63B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $10.25B | Feb 25, 2026 |
| FY2023 | Dec 31, 2022 | $9.83B | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $8.88B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $10.70B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $11.74B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $13.99B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $12.23B | Mar 8, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.46B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $6.96B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $8.24B | Feb 24, 2025 |
| FY2023 | Dec 31, 2022 | $4.28B | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $5.19B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $6.18B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $4.41B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $4.47B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $4.81B | Mar 8, 2019 |
| FY2018 | Dec 31, 2016 | $5.65B | Mar 8, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (4) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | (1) | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | (1) | Feb 27, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (4) | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 3 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | (1) | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | (1) | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | (1) | Feb 27, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 283.36M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 309.90M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 333.88M | Feb 24, 2025 |
| FY2023 | Dec 31, 2022 | 365.08M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | 391.29M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | 440.78M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | 463.71M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | 528.86M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 561.00M | Mar 8, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $314.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $302.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $301.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $294.00M | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $296.00M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $297.00M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $285.00M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $157.00M | Feb 24, 2021 |
| FY2018 | Dec 31, 2016 | $1.05B | Mar 8, 2019 |